Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort
Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort
复制标题
日本监管部门批准测试的四种肌炎特异性自身抗体的临床特征：日本多中心成人肌炎患者队列
DOI：
10.1016/j.jdermsci.2021.05.005
复制
发表时间：
2021
期刊：
影响因子：
4.6
通讯作者：
Kuwana M.
中科院分区：
文献类型：
--
作者：
Ueda-Hayakawa I;Fujimoto M;Sato S;Murakami A;Kawakami A;Mishima M;Seishima M;Suda T;Takehara K;Mimori T;Kuwana M.
[6]H. Cao，M.潘湾，澳-地Kang，Q. Xia，X. Li，X. Zhao河，巴西-地Shi，J. Lou，M. Zhou，M.库瓦纳、X. Ding，J. Zheng，具有抗黑色素瘤分化相关基因5抗体阳性表达的皮肌炎和临床无肌病性皮肌炎患者的临床表现，关节炎护理研究（Hoboken）64（10）（2012）1602-10。[7]Z. Chen，M. J. Liang，H. Cai，M.库瓦纳湖Sun，Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease：a review of the literature and a meta-analysis，Arthritis Care Res（Hoboken）65（8）（2013）1316-24. [8]D.菲奥伦蒂诺湖Chung，J. Zwerner，A.罗森湖Casciola-Rosen，MDA 5抗体（CADM-140）皮肌炎患者的粘膜皮肤和全身表型：回顾性研究，J Am Acad Dermatol 65（1）（2011）25-34。[9]LA Love，RL Leff，DD Fraser，IN Targoff，M. Dalakas，PH Plotz，FW米勒，特发性炎性肌病分类的新方法：肌炎特异性自身抗体定义了有用的同质患者组。医学（巴尔的摩）70（6）（1991）360-74。
[6] H. Cao, M. Pan, Y. Kang, Q. Xia, X. Li, X. Zhao, R. Shi, J. Lou, M. Zhou, M. Kuwana, X. Ding, J. Zheng, Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody, Arthritis Care Res (Hoboken) 64 (10)(2012) 1602-10.[7] Z. Chen, M. Cao, MN Plana, J. Liang, H. Cai, M. Kuwana, L. Sun, Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis, Arthritis Care Res (Hoboken) 65 (8)(2013) 1316-24.[8] D. Fiorentino, L. Chung, J. Zwerner, A. Rosen, L. Casciola-Rosen, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study, J Am Acad Dermatol 65 (1)(2011) 25-34.[9] LA Love, RL Leff, DD Fraser, IN Targoff, M. Dalakas, PH Plotz, FW Miller, A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups., Medicine (Baltimore) 70 (6)(1991) 360-74.